Literature DB >> 31809423

Expectant Management of Hypertensive Disorders of Pregnancy and Future Cardiovascular Morbidity.

Joshua I Rosenbloom1, Adam K Lewkowitz, Kathryn J Lindley, D Michael Nelson, George A Macones, Alison G Cahill, Margaret A Olsen, Molly J Stout.   

Abstract

OBJECTIVE: To test the hypothesis that a longer length of time between diagnosis of hypertensive disorders of pregnancy and delivery is associated with increased risk of cardiovascular morbidity in the years after delivery.
METHODS: This is a retrospective cohort study based in the New York State Inpatient Database. The first delivery for all patients from 2005 to 2014 who delivered preterm with an International Classification of Diseases, 9th Revision, Clinical Modification code for hypertensive disorders of pregnancy (excluding isolated chronic hypertension) was included. The duration between diagnosis and delivery was divided into 7 days or less or more than 7 days. The primary outcome was admission for a composite of cardiovascular disease, stroke, or death after the index delivery through December 31, 2014.
RESULTS: There were 22,594 patients with a median follow-up period of 5.2 years: 19,750 (87.4%) were delivered within 7 days of diagnosis and 2,844 (12.6%) were delivered more than 7 days from diagnosis. The primary outcome occurred in 216 (1.1%) patients in the 0-7 days group (21 events/10,000 person-years) and 67 (2.4%) patients in the more than 7 days group (46 events/10,000 person-years), adjusted hazard ratio 1.45 (95% CI 1.09 to 1.93). The findings were robust in a number of sensitivity analyses.
CONCLUSIONS: Prolonged expectant management of preterm hypertensive disorders of pregnancy is associated with an increased risk of maternal cardiac disease in the ensuing years.

Entities:  

Mesh:

Year:  2020        PMID: 31809423      PMCID: PMC6923587          DOI: 10.1097/AOG.0000000000003567

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.623


  25 in total

1.  ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia.

Authors: 
Journal:  Obstet Gynecol       Date:  2019-01       Impact factor: 7.661

2.  A note on quantifying follow-up in studies of failure time.

Authors:  M Schemper; T L Smith
Journal:  Control Clin Trials       Date:  1996-08

3.  The utility of ICD9-CM codes in identifying induction of labor.

Authors:  Lisa D Levine; Meghana Limaye; Sindhu K Srinivas
Journal:  Am J Perinatol       Date:  2014-09-28       Impact factor: 1.862

4.  Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.

Authors:  Kim Broekhuijsen; Gert-Jan van Baaren; Maria G van Pampus; Wessel Ganzevoort; J Marko Sikkema; Mallory D Woiski; Martijn A Oudijk; Kitty W M Bloemenkamp; Hubertina C J Scheepers; Henk A Bremer; Robbert J P Rijnders; Aren J van Loon; Denise A M Perquin; Jan M J Sporken; Dimitri N M Papatsonis; Marloes E van Huizen; Corla B Vredevoogd; Jozien T J Brons; Mesrure Kaplan; Anton H van Kaam; Henk Groen; Martina M Porath; Paul P van den Berg; Ben W J Mol; Maureen T M Franssen; Josje Langenveld
Journal:  Lancet       Date:  2015-03-25       Impact factor: 79.321

5.  Induction of labour or expectant monitoring in hypertensive pregnancy disorders at term: do women's postpartum cardiovascular risk factors differ between the two strategies?

Authors:  Wietske Hermes; Corine M Koopmans; Maria G van Pampus; Arie Franx; Kitty W M Bloemenkamp; Joris van der Post; Martina Porath; Jouke T Tamsma; Ben W Mol; Christianne J M de Groot
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-08-11       Impact factor: 2.435

Review 6.  Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Cheryl Bushnell; Louise D McCullough; Issam A Awad; Monique V Chireau; Wende N Fedder; Karen L Furie; Virginia J Howard; Judith H Lichtman; Lynda D Lisabeth; Ileana L Piña; Mathew J Reeves; Kathryn M Rexrode; Gustavo Saposnik; Vineeta Singh; Amytis Towfighi; Viola Vaccarino; Matthew R Walters
Journal:  Stroke       Date:  2014-02-06       Impact factor: 7.914

Review 7.  Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologists.

Authors:  Haywood L Brown; John J Warner; Eugenia Gianos; Martha Gulati; Alexandria J Hill; Lisa M Hollier; Stacey E Rosen; Mary L Rosser; Nanette K Wenger
Journal:  Circulation       Date:  2018-05-10       Impact factor: 29.690

8.  Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial.

Authors:  B M Sibai; B M Mercer; E Schiff; S A Friedman
Journal:  Am J Obstet Gynecol       Date:  1994-09       Impact factor: 8.661

9.  Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy.

Authors:  Jennifer L Jarvie; Torri D Metz; Melinda B Davis; Jessica C Ehrig; David P Kao
Journal:  Heart       Date:  2018-01-11       Impact factor: 5.994

10.  Markers of cardiovascular disease risk after hypertension in pregnancy.

Authors:  George J Mangos; Julia J Spaan; Saiyini Pirabhahar; Mark A Brown
Journal:  J Hypertens       Date:  2012-02       Impact factor: 4.844

View more
  5 in total

1.  Preeclampsia Predicts Risk of Hospitalization for Heart Failure With Preserved Ejection Fraction.

Authors:  Dominique Williams; Molly J Stout; Joshua I Rosenbloom; Margaret A Olsen; Karen E Joynt Maddox; Elena Deych; Victor G Davila-Roman; Kathryn J Lindley
Journal:  J Am Coll Cardiol       Date:  2021-12-07       Impact factor: 24.094

2.  Health Outcomes Associated With Clinician-initiated Delivery for Hypertensive Disorders at 34-38 Weeks' Gestation.

Authors:  David A Savitz; Valery A Danilack; Jerson Cochancela; Brenna L Hughes; Dwight J Rouse; Roee Gutmann
Journal:  Epidemiology       Date:  2022-03-01       Impact factor: 4.822

Review 3.  Hypertensive Disorders of Pregnancy and Heart Failure Risk.

Authors:  Sarah A Goldstein; Neha J Pagidipati
Journal:  Curr Hypertens Rep       Date:  2022-03-28       Impact factor: 4.592

4.  Latency of preterm hypertensive disorders of pregnancy and subsequent cardiovascular complications.

Authors:  Joshua I Rosenbloom; Dustin Stwalley; Kathryn J Lindley; D Michael Nelson; Margaret A Olsen; Molly J Stout
Journal:  Pregnancy Hypertens       Date:  2020-05-31       Impact factor: 2.899

Review 5.  Hypertensive Disorders of Pregnancy.

Authors:  Apurva M Khedagi; Natalie A Bello
Journal:  Cardiol Clin       Date:  2020-11-02       Impact factor: 2.213

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.